News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
FDA Warns Baxter International, Inc. on Surgical Sealant Promotion
May 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- U.S. regulators have warned Baxter International Inc that promotions for the company's Tisseel surgical sealant were misleading, a letter released on Tuesday said.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Baxter International, Inc.
MORE ON THIS TOPIC
IN PARTNERSHIP WITH SK PHARMTECO
The supply chain fault lines of modern pharma
September 10, 2026
·
1 min read
·
Jennifer C. Smith-Parker
FDA
Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
September 9, 2026
·
1 min read
·
Jef Akst
Regulatory
Acting CBER, CDER heads become permanent as FDA works to restore stability
September 9, 2026
·
2 min read
·
Tristan Manalac
Approvals
AstraZeneca’s SERD pill overcomes adcomm defeat to win FDA nod in breast cancer
September 8, 2026
·
2 min read
·
Tristan Manalac